We describe a case of localized gastrocnemius myositis which developed with flare-up of Crohn's disease. A 21-year old male patient with an 8-year history of Crohn's disease presented with pain and tenderness in both calves without recent abdominal symptoms. Electromyography and gastrocnemius muscle biopsy revealed evidence of inflammatory myositis. Magnetic resonance imaging (MRI) showed bilateral symmetrical diffuse increased signal intensity in T2 weighted images in both gastrocnemius muscles and patchy contrast enhancement. Subsequent gastrointestinal investigation revealed active inflammation of colon with multiple pseudopolyps and enteroenteric fistula on which we commenced oral prednisolone of 30 mg daily. His pain on both calves was improved and muscle enzymes became normal. Following dose reduction of prednisolone, azathioprine 50 mg daily was started considering the patient's active Crohn's disease on endoscopic findings prior to the development of overt abdominal symptoms. This is the first case report of localized gastrocnemius myositis associated with Crohn's disease described in Korea. Calf myositis responded to corticosteroid well and did not recur with maintenance therapy using azathioprine and mesalazine.
Introduction
Musculoskeletal involvement is a common extraintestinal manifestation of inflammatory bowel disease (IBD) (6∼64%) which includes pauci-, poly-arthritis, myalgia, diffuse inflammatory myositis such as polymyositis, dermatomyositis enthesitis, localized joint pain, axial spondyloarthropathies and fibromyalgia-like symptoms (1).
Localized gastrocnemius myositis was is rare, but also described as one of typical extraintestinal manifestation of IBD.
To date, nine cases of IBD related gastrocnemius myositis have been reported presenting calf-confined myalgia, which were preceding or following the diagnosis of IBD (2) . Herein we report a patient with localized gastrocnemius myositis followed by a flare of Crohn's disease.
Case Report
A 21-year-old man presented with acute onset of pain and tenderness in both calves causing difficulty in ambulation for 1 month. He was referred to division of rheumatology. The patient denied any trauma nor any systemic symptom. He had a history of Crohn's disease for 8 years. He had experienced a flare related to Crohn's disease 7 years earlier with anal fistula, anorexia, diarrhea and weight loss of 12 kg, and endoscopic investigation had found typical lesions of Crohn's disease. After treatment with 40 mg of daily of oral prednisolone, mesalazine 500 mg three times daily, azathioprine 50 mg daily, metronidazole 250 mg three times daily since then, he was currently on remission status and the only medication he was taking were mesalazine three times daily without specific bowel symptoms. Colonoscopic findings of 1 year earlier to this event was normal.
On physical examination, significant tenderness in both calves without erythema or edema was noticed. He had no evidence of skin rashes, arthralgia, muscle weakness or sen- The patient continued to take prednisolone 5 mg daily, azathioprine 50 mg daily, mesalazine 500 mg three times daily.
Discussion
Gastrocnemius myalgia syndrome is rare extraintestinal manifestations, Up to date, 9 cases have been reported (2). To our knowledge this is the first case reported in Korea.
Musculoskeletal symptom preceded gastrointestinal symptom It is not known why myositis associated with IBD is confined to gastrocnemii, possible explanation may be shared T-cell mediated inflammatory immune mechanism for both the bowel and muscle inflammation (2) . Infectious agents such as Campylobacter, Borrelia burgdorferi or BCG vaccination have been suggested for triggering gastrocnemius myositis and it may be another start of explanations (7) . There was no other muscle involvement in our patient except both calves.
Summary
In this case of localized gastrocnemius myositis, muscle symptom called on attending physician to embark gastrointestinal investigation prior to development of overt symp- Collaboration between gastroenterologists and rheumatologists for appropriate approach to musculoskeletal manifestations in IBD is demanded.
